NDC 65841-803

acyclovir

Acyclovir

acyclovir is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Acyclovir.

Product ID65841-803_6ea37c6b-828b-4643-974f-e65ceedfa368
NDC65841-803
Product TypeHuman Prescription Drug
Proprietary Nameacyclovir
Generic NameAcyclovir
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-09-10
Marketing CategoryANDA / ANDA
Application NumberANDA204314
Labeler NameZydus Lifesciences Limited
Substance NameACYCLOVIR
Active Ingredient Strength800 mg/1
Pharm ClassesDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 65841-803-01

100 TABLET in 1 BOTTLE (65841-803-01)
Marketing Start Date2014-09-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65841-803-05 [65841080305]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA204314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-09-10

NDC 65841-803-30 [65841080330]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA204314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-09-10

NDC 65841-803-06 [65841080306]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA204314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-09-10

NDC 65841-803-01 [65841080301]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA204314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-09-10

NDC 65841-803-10 [65841080310]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA204314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-09-10

NDC 65841-803-16 [65841080316]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA204314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-09-10

Drug Details

Active Ingredients

IngredientStrength
ACYCLOVIR800 mg/1

OpenFDA Data

SPL SET ID:8d9fea43-6c04-40d7-8aac-398c2de2a558
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197311
  • 197313

    • Pharmacological Class

    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]

    NDC Crossover Matching brand name "acyclovir" or generic name "Acyclovir"

    NDCBrand NameGeneric Name
    0093-3630Acycloviracyclovir
    0093-8940AcyclovirAcyclovir
    0093-8943AcyclovirAcyclovir
    0093-8947AcyclovirAcyclovir
    0143-9657AcyclovirAcyclovir
    0143-9658AcyclovirAcyclovir
    0168-0825acycloviracyclovir
    0378-8700Acycloviracyclovir
    0378-8712AcyclovirAcyclovir
    0440-6030AcyclovirAcyclovir
    0440-7033acycloviracyclovir
    0472-0082AcyclovirAcyclovir
    0591-1159Acycloviracyclovir
    0713-0630AcyclovirAcyclovir
    0904-5789ACYCLOVIRACYCLOVIR
    0904-5790acycloviracyclovir
    10544-039Acycloviracyclovir
    10544-089Acycloviracyclovir
    10544-101AcyclovirAcyclovir
    68071-1841AcyclovirAcyclovir
    68071-3155AcyclovirAcyclovir
    68071-3222AcyclovirAcyclovir
    68071-4528AcyclovirAcyclovir
    68071-4559acycloviracyclovir
    68071-4345AcyclovirAcyclovir
    68084-109AcyclovirAcyclovir
    68084-108AcyclovirAcyclovir
    68071-4790AcyclovirAcyclovir
    68071-4799AcyclovirAcyclovir
    68084-107ACYCLOVIRACYCLOVIR
    68382-125acycloviracyclovir
    68382-049acycloviracyclovir
    68382-048acycloviracyclovir
    68382-668acycloviracyclovir
    68382-126acycloviracyclovir
    68382-792acycloviracyclovir
    68382-791acycloviracyclovir
    68382-992acycloviracyclovir
    68462-746acycloviracyclovir
    68788-6360acycloviracyclovir
    68788-0505AcyclovirAcyclovir
    68788-0504AcyclovirAcyclovir
    68788-0715AcyclovirAcyclovir
    68788-8989acycloviracyclovir
    68788-6827ACYCLOVIRACYCLOVIR
    68788-7382acycloviracyclovir
    68788-7378acycloviracyclovir
    68788-9783AcyclovirAcyclovir
    68788-7342AcyclovirAcyclovir
    68788-9690AcyclovirAcyclovir
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.